A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cells

Peter J. Cook, David J. Rawlings(Center for Infectious Disease Research), Karen Sommer, Annaiz Grimm, Andrew M. Scharenberg(CTI BioPharma (Italy)), Chester Jacobs, Andrea Repele(University of North Dakota), Samuel E. West, Noelle Dahl, Travis Drow, Lijie Wang(National Institute for Viral Disease Control and Prevention), Ahmad Boukhris, Su Jung Yang, Gene Uenishi(University of Wisconsin–Madison)
Molecular Therapy
May 4, 2023
Cited by 25


Related Papers